Cancer sufferers risk losing access to effective drugs, says support group Medicine regulator Nice will act as gatekeeper for new treatments, leading to fears NHS patients may be denied them on cost grounds
Cancer patients in the UK will miss out on drugs available in other countries under new arrangements for deciding which expensive medicines the NHS will pay for, according to a charity.
Breast Cancer Now has criticised the relaunched Cancer Drugs Fund (CDF), which was originally a pot of money to pay for costly new medicines not considered cost effective or not yet assessed by the National Institute for Health and Care Excellence (Nice). Continue reading... The Guardian
No comments:
Post a Comment